“2018 China FSMP Industry Report” along with the consecutive report “FSMP Industry: Strategy and Operation” are the guidelines for the investment and operation of China FSMP(Foods for Special Medical Purpose) Industry, effectively support the development of following strategy
Operation Strategy: Segmentation and Position, New Product Development, Channel Strategy and Media Strategy
Investment Strategy: Industry Size and Forecast, Barriers and Drivers, Competition and Profit Ratio
This report focus more on data and information, “FSMP Industry: Insight and Operation” discuss the industry strategy in depth based on the depth interviewing of 20 industry experts.
Although the focus of two reports differ, the former more on data, the latter more on strategy, the two reports can both help to figure out the dynamic of industry, understand the trends and avoid the risk of investment and operation.
Targets
- Manufacturer and Importer of FSMP
- Investor of FSMP
- Upstream and downstream firms, including material provider, techniques provider, manufacturer, channels (drugstore, supermarket, Mom & Baby Store, e-commerce) and sales agency
- Government organization and medical department
Unique Selling Points
- Credible and reliable data: data is from firsthand database and ad hoc research, as well as secondary database including industry associations, annual report and national statistics; the data from different resources verify each other
- Up to date data: 2015, 2016 and 2017 data are adopted; FSMP industry experienced high growth in the past 10 years, only up to date data can reflect the real status of market
- Highly qualified and experienced researchers consists of marketing researcher, medical expert and government affairs experts and marketing experts, with international MBA, medical and data analysis background and nearly 20 years of average working experience
- Sufficient report development time with more than eight months (from Dec., 2017 to Aug. 2018) in planning, collecting, interviewing, analysis and writing
Research Methodology
- Retail audit
- Expert depth interviewing
- Consumer insight
Secondary Data from National Bureau of Statistics、Industry Association, Annual Reports etc
Table of Contents
Preface
i Research Purpose
ii Target Audience
iii USP
iv Research Scope
v Research Methodology
1. Executive Summary
1.1 Total FSMP
1.2 Adult FSMP
1.3 Special Formula
2. Total FSMP
2.1 Size, GR and Forecast(China vs. Global,2015;2016,2017,2018-2022 )
2.2 Key Events & Regulations (China vs. Global)
2.3 Definition of FSMP in different countries
2.4 Conclusion
3. Adult FSMP
3.1 Size, GR & Forecast (China vs. Global,2015,2016,2017,2018-2022 )
3.1.1 By Application Type (General, Specific)
3.1.2 By Channel (Hospital, Pharmacy, E-commerce)
3.2 Opportunity Analysis of Key Segments by Disease (Disease Incidence, Malnutrition Incidence, Length of illness, the substitutability of FSMP)
3.3 Industry Analysis
3.3.1 Competition Analysis
3.3.1.1 Market Share and Concentration
3.1.2.2 Product Grouping and Characteristic
3.3.2 Market Driver
3.3.3 Entry and Exit Barriers
3.3.4 Consumer Insight(Awareness, Penetration, Willing to Purchase etc)
3.3.5 Channel Analysis(Hospital, Pharmacy, E-commerce, Nursing Home etc)
3.3.6 Media Tools Analysis (Traditional, Internet and Scene Marketing)
3.7 Conclusion
4. Special Formula
4.1 Scale growth and forecas
4.1.1 Channel Analysis(Hospital, Pharmacy, E-commerce, Nursing Home , etc.)
4.1.2 By Channel (FP&MBS, Pharmacy, E-commerce)
4.2 Opportunity Analysis of Key Segments by Disease (Disease Incidence, Malnutrition Incidence, Length of illness, the substitutability of FSMP)
4.3 Industry Analysis
4.3.1 Competition Analysis
4.3.1.1 Market Share and Concentration
4.3.1.2 Product Grouping and Characteristic
4.3.2 Market Driver
4.3.3 Entry and Exit Barriers
4.3.4 Consumer Insight(Birthrate, Penetration, Willing to Purchase etc)
4.3.5 Channel Analysis(FP&MBS, Pharmacy, E-commerce)
4.3.6 Media Tools Analysis (Traditional, Internet and Scene Marketing)
4.7 Conclusion
5. Company Profile (Strategy, Finance performance, Product etc)
5.1 Abbott Laboratories
5.2 Nestle Health Science
5.3 Danone Nutricia
5.5 Fresenius Kabi
5.6 Leskon
5.7 Beingmate
5.8 Conclusion
6. FSMP Regulation
6.1 Regulation of R&D Process
6.2 Regulation of Registration
6.3 Summary of the Status of Registration
Contact：Sophie
E-mail:sophie@cre-ability.com
